EUVIMEDOpdag EUVIMED
Open access

Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma

Qiang Tang, Shurui Wang, Huimin Li, Junzhi Liu, Xin Hu, Dong Zhao, Maojun Di

Aging · 2024-01-10

DOI: 10.18632/aging.205398 ↗

At a glance

Journal article in Aging, published online on 2024-01-10. Written by Qiang Tang and 6 co-authors. Institution: Department of Gastrointestinal Surgery, Shiyan Taihe Hospital, Hubei University of Medicine, Hubei Province, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 2 times so far (Crossref); 37 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

TM4SF family members (TM4SFs) have been shown to be aberrantly expressed in multiple types of cancer. However, a comprehensive investigation of the TM4SFs has yet to be performed in LIHC. The study comprehensively investigated the expression and prognostic value of TM4SFs. Then, a TM4SFs-based risk model and nomogram were constructed for prognostic prediction. Finally, functional loss of TM4SFs was performed to verify the potential role of TM4SFs in LIHC. We found that TM4SFs were significantly up-regulated in LIHC. High expression and hypomethylation of TM4SFs were associated with poor prognosis of LIHC patients. Then, a TM4SFs-based risk model was constructed that could effectively classify LIHC patients into high and low-risk groups. In addition, we constructed a prognostic nomogram that could predict the long-term survival of LIHC patients. Based on immune infiltration analysis, high-risk patients had a relatively higher immune status than low-risk patients. Moreover, the prediction module could predict patient responses to immunotherapy and chemotherapy. Finally, loss-of-function studies showed that TM4SF4 knockdown could substantially suppress the growth, migratory, and invasive abilities of LIHC cells. Targeting TM4SFs will contribute to effective immunotherapy strategies and improve the prognosis of liver cancer patients.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansPrognosisMultiomicsImmunotherapyMembrane Glycoproteins

Author keywords

TM4SFsexpressionprognostictherapeutic targettumor-infiltrating immune

Substances

TM4SF4 protein, humanMembrane Glycoproteins

Authors and institutions

  • Department of Gastrointestinal Surgery, Shiyan Taihe Hospital, Hubei University of Medicine, Hubei Province, China.
  • The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
  • School of Nursing, Peking Union Medical College, Beijing, China.
  • Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.

Cite

APA

Tang, Q., Wang, S., Li, H., Liu, J., Hu, X., Zhao, D., & Di, M. (2024). Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma. Aging. https://doi.org/10.18632/aging.205398

Vancouver

Tang Q, Wang S, Li H, Liu J, Hu X, Zhao D, et al. Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma. Aging. 2024. doi:10.18632/aging.205398

BibTeX
@article{Tang2024,
  author = {Tang, Qiang and Wang, Shurui and Li, Huimin and Liu, Junzhi and Hu, Xin and Zhao, Dong and Di, Maojun},
  title = {Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205398}
}
Start for free →